AKUMIN INC (AKU)

US01021X1000 - Common Stock

0.2887  -0.06 (-17.87%)

After market: 0.2875 0 (-0.42%)

Fundamental Rating

3

Overall AKU gets a fundamental rating of 3 out of 10. We evaluated AKU against 116 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of AKU have multiple concerns. AKU is quite expensive at the moment. It does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

In the past year AKU has reported negative net income.
AKU had a positive operating cash flow in the past year.
In the past 5 years AKU reported 4 times negative net income.
Each year in the past 5 years AKU had a positive operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -9.35%, AKU is doing worse than 66.96% of the companies in the same industry.
AKU has a Return On Invested Capital (2.58%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for AKU is significantly below the industry average of 8.65%.
The 3 year average ROIC (1.89%) for AKU is below the current ROIC(2.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -9.35%
ROE N/A
ROIC 2.58%
ROA(3y)-5.55%
ROA(5y)-3.32%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)1.89%
ROIC(5y)2.77%

1.3 Margins

AKU has a Operating Margin of 6.78%. This is in the better half of the industry: AKU outperforms 72.17% of its industry peers.
AKU's Operating Margin has improved in the last couple of years.
AKU has a Gross Margin of 25.32%. This is comparable to the rest of the industry: AKU outperforms 49.57% of its industry peers.
AKU's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.78%
PM (TTM) N/A
GM 25.32%
OM growth 3Y9.52%
OM growth 5Y35.6%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.3%
GM growth 5Y-16.74%

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AKU is destroying value.
Compared to 1 year ago, AKU has more shares outstanding
AKU has more shares outstanding than it did 5 years ago.
The debt/assets ratio for AKU is higher compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.30, we must say that AKU is in the distress zone and has some risk of bankruptcy.
AKU's Altman-Z score of 0.30 is on the low side compared to the rest of the industry. AKU is outperformed by 66.96% of its industry peers.
The Debt to FCF ratio of AKU is 59.58, which is on the high side as it means it would take AKU, 59.58 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 59.58, AKU perfoms like the industry average, outperforming 46.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 59.58
Altman-Z 0.3
ROIC/WACC0.59
WACC4.35%

2.3 Liquidity

A Current Ratio of 1.09 indicates that AKU should not have too much problems paying its short term obligations.
AKU's Current ratio of 1.09 is on the low side compared to the rest of the industry. AKU is outperformed by 70.43% of its industry peers.
AKU has a Quick Ratio of 1.09. This is a normal value and indicates that AKU is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AKU (1.09) is worse than 61.74% of its industry peers.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09

5

3. Growth

3.1 Past

The earnings per share for AKU have decreased strongly by -118.41% in the last year.
AKU shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.20%.
AKU shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 59.26% yearly.
EPS 1Y (TTM)-118.41%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-13.13%
Revenue 1Y (TTM)38.2%
Revenue growth 3Y50.24%
Revenue growth 5Y59.26%
Revenue growth Q2Q0.71%

3.2 Future

The Earnings Per Share is expected to grow by 29.98% on average over the next years. This is a very strong growth
Based on estimates for the next years, AKU will show a small growth in Revenue. The Revenue will grow by 5.00% on average per year.
EPS Next Y45.08%
EPS Next 2Y29.98%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.13%
Revenue Next 2Y5%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

AKU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AKU is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AKU indicates a rather cheap valuation: AKU is cheaper than 81.74% of the companies listed in the same industry.
AKU's Price/Free Cash Flow ratio is rather cheap when compared to the industry. AKU is cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 1.18
EV/EBITDA 8.75

4.3 Compensation for Growth

A more expensive valuation may be justified as AKU's earnings are expected to grow with 29.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.98%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for AKU!.
Industry RankSector Rank
Dividend Yield N/A

AKUMIN INC

NASDAQ:AKU (10/25/2023, 7:00:00 PM)

After market: 0.2875 0 (-0.42%)

0.2887

-0.06 (-17.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap25.84M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.35%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 6.78%
PM (TTM) N/A
GM 25.32%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-118.41%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y45.08%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)38.2%
Revenue growth 3Y50.24%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y